The Lancet: July 30, 2010
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
Discussion of HDL cholesterol as an indicator of cardiovascular risk after lipid-lowering therapy to reduce LDL cholesterol. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
